(Total Views: 470)
Posted On: 09/10/2019 9:29:18 PM
Post# of 72440
Excellent points.
After three more partnerships? Well it's going to go up probably. By many dollars. As long as they secure significantly better terms than we did with B-UP.
The question is how far do those three indications need to be advanced to get that sort of partnership? B-ABSSSI, which you didn't mention there, is our most advanced drug candidate with the most rock solid results (200+ patient phase 2b completed with outstanding results). It finished that trial five years ago and there is still no sign of partnership on it.
Quote:
What is going to happen to IPIX SP when IPIX secures a lucrative IBD pill partnership with a major pharma for Colitis? How about a separate B-OM partnership? A Kevetrin trial advancement and/or partnership?
After three more partnerships? Well it's going to go up probably. By many dollars. As long as they secure significantly better terms than we did with B-UP.
The question is how far do those three indications need to be advanced to get that sort of partnership? B-ABSSSI, which you didn't mention there, is our most advanced drug candidate with the most rock solid results (200+ patient phase 2b completed with outstanding results). It finished that trial five years ago and there is still no sign of partnership on it.
(1)
(1)Scroll down for more posts ▼
